Emergent BioSolutions
-$1.97 (-3.01%) Today
+$1.07 (+1.68%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell EBS and other stocks, options, and ETFs commission-free!
About EBS
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats.
CEO
Robert G. Kramer
Employees
2,200
Headquarters
Gaithersburg, Maryland
Founded
1998
EBS Key Statistics
Market Cap
3.40B
Price-Earnings Ratio
8.87
Dividend Yield
—
Average Volume
778.05K
High Today
$66.12
Low Today
$62.72
Open Price
$65.52
Volume
829.05K
52 Week High
$137.61
52 Week Low
$55.07
EBS News
New York TimesJun 11
F.D.A. Tells Johnson & Johnson That60 Million Vaccine Doses Cannot Be Used
WASHINGTON — Federal regulators said on Friday that millions of doses of Johnson & Johnson’s coronavirus vaccine produced at a troubled Baltimore factory could
CNNJun 11
FDA authorizes two batches of Johnson & Johnson Covid-19 vaccine doses from Baltimore plant
(CNN) The US Food and Drug Administration announced Friday it was authorizing for use two batches of Johnson & Johnson Covid-19 vaccines that were produced at t
Business InsiderJun 11
Johnson & Johnson has to throw away 60 million vaccine doses because of possible contamination at the beleaguered Emergent BioSolutions plant
The Food and Drug Administration has told Johnson & Johnson to throw out about 60 million COVID-19 vaccine doses from a beleaguered plant, people familiar with
Analyst Ratings
56%
of 9 ratings
Buy
55.6%
Hold
44.4%
Sell
0%
EBS Earnings
$0.00
$1.22
$2.45
$3.67
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Jul 29, After Hours